Cantel Medical Corporation
150 Clove Road, 9th Floor
226 articles with Cantel Medical Corporation
Cantel Promotes Peter Clifford to Chief Operating Officer and Appoints Shaun Blakeman as Chief Financial Officer
Leadership changes to advance growth and strengthen focus to better align with business needs
Ms. Casner will serve on the Executive Leadership Team and report to George Fotiades, President and CEO.
Former President and COO of Cardinal Health Succeeds Jorgen B. Hansen
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Second Quarter Ended January 31, 2019
CANTEL MEDICAL CORP. will release the results for its second quarter ended January 31, 2019 on Thursday, February 28, 2019 before the market opens, and hold a conference call to discuss the results at 9:30 a.m. ET.
CANTEL MEDICAL CORP. announced that it has completed its previously announced acquisition of Omnia S.p.A.
Acquisition enhances Cantel's Dental water solutions portfolio and advances global leadership position in infection prevention
Cantel Medical Corporation (NYSE: CMD) announced today that Peter Clifford, Executive Vice President and CFO, will be presenting at the 21st Annual Needham Growth Conference at the Lotte New York Palace Hotel in New York.
Cantel Medical Corporation (NYSE: CMD) announced today that its Board of Directors approved an increase in its semiannual cash dividend from $0.085 to $0.10 per outstanding share of the Company's Common Stock.
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2018
CANTEL MEDICAL CORP. will release the results for its first quarter ended October 31, 2018 on Thursday, November 29, 2018 before the market opens, and hold a conference call to discuss the results at 11:00 a.m. ET.
Acquisition of dental surgical consumables company will accelerate Company's dental infection prevention presence in Europe
Mr. Haydon will serve on the Executive Leadership Team and report to Jorgen B. Hansen, President and CEO.
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Fourth Quarter and Year Ended July 31, 2018
In addition, during the conference call, the Company will provide financial guidance with respect to the full fiscal year ending July 31, 2019.
Cantel Medical to Present at the Raymond James 14th Annual North American Equities Conference in London, England
Cantel Medical Corp. announced today that Peter Clifford, Executive Vice President and CFO, will be presenting at the Raymond James 14th Annual North American Equities Conference at the Four Seasons London at Park Lane in London, England.
Cantel Expands its Life Sciences Portfolio through Acquisition of Stericycle's Controlled Environmental Solutions Business
Addition of clean room business enhances and strengthens Cantel's portfolio of infection prevention solutions
Amended Credit Agreement Provides for Expanded Borrowing Capacity to Support Strategic Growth
Innovative technology from Crosstex, Cantel Medical's Healthcare Disposables Division, expands its dental water compliance portfolio and provides solution to help meet the compliance needs of dental practices
Cantel Medical Corp. (NYSE: CMD) today announced financial results for its third quarter ended April 30, 2018.
Cantel Medical Receives FDA 510(k) Clearance to Market ADVANTAGE PLUS® Pass-Thru Automated Endoscope Reprocessor
First-of-its-kind innovative design in the U.S. enhances patient safety by providing best-in-class infection prevention for flexible endoscopes
Cantel Medical to Participate in Fireside Chat at the 17th Annual Needham & Company Healthcare Conference
CANTEL MEDICAL CORP. (NYSE: CMD) announced today that Jorgen B. Hansen, President and CEO, will be participating in an analyst-led fireside chat with investors at the 17th Annual Needham & Company Healthcare Conference at the Westin Grand Central Hotel in New York, on Tuesday, March 27 at 4:30 p.m. ET.
Cantel Medical Corporation announced financial results for its second quarter ended January 31, 2018.